Susquehanna International Group, LLP Takeda Pharmaceutical CO LTD Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 10,810 shares of TAK stock, worth $150,042. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,810
Previous 47,029
77.01%
Holding current value
$150,042
Previous $699,000
76.11%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding TAK
# of Institutions
368Shares Held
73MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$185 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$106 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$62.5 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$55.9 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$51.5 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...